Engineered Monkeypox Protein A29L Protein (His Marker): A Research Resource
Engineered Monkeypox Protein A29L Protein (His Marker): A Research Resource
Blog Article
This produced Orthopoxvirus A29 protein, featuring a His label, represents a valuable research instrument for analysis of viral functions and possible therapeutic goals. The His tag allows for easy isolation and assessment using conventional affinity methods, making it suitable for multiple experiments including immune association assays, crystallization, and molecule expression studies. Ultimately, Recombinant MPXV A29L Protein(His Tag) this produced molecule provides a reproducible way to advance insight of Monkeypox pathogenesis.
Production and Characterization of Recombinant MPXV A29L Protein (His Tag)
The optimized production of recombinant MPXV A29L molecule, tagged with a His sequence, was realized using *E. coli* expression platform. Preliminary attempts involved inserting the A29L DNA into a plasmid system followed by transformation into competent *E. coli* populations. Afterwards, refined growth conditions were defined to increase yield. Extraction of the His-tagged A29L protein was conducted utilizing immobilized metal affinity resin. Analysis involved methods such as SDS-PAGE, Western blotting, and mass analysis to validate authenticity and evaluate molecular weight and purity. The obtained recombinant A29L protein exhibited appropriate mass and suggested the presence of the His tag, confirming complete generation and isolation.
Engineered Monkeypox Virus A29L Antigen (His Tag|with a His-tag|His-tagged) for Monkeypox Virus Studies
The supply of recombinant MPXV A29L antigen (His Label) represents a critical reagent for advancing investigations into the mechanism of monkeypox virus. This construct facilitates straightforward quantification and separation through metal chromatography, allowing for detailed analysis of its functional properties, binding with immune factors, and potential in viral infection. The His marker serves as a practical handle for efficient generation and purification, contributing it ideally suited for a set of MPXV trials.
Optimizing Synthesis of Engineered MPXV A29L Molecule (His Tag | with a His Tag | tagged with His | featuring a His tag)
To achieve high yields of the expressed MPXV A29L factor , numerous parameters require precise adjustment . Early attempts involved typical expression in *E. coli*, however, this often resulted in limited quantities and substantial inclusion aggregate formation. Therefore , techniques such as adjusting the signal strength, improving the culture settings, and employing supporting components to promote proper structure were utilized . Additionally , exploring different expression systems , such as cells, is being assessed to even maximize output and refine molecule purity .
Applications of Recombinant MPXV A29L Protein (His Tag) in Diagnostics
Recombinant MPXV A29L protein (His tag) demonstrates crucial application in enhancing accurate identification assays for variola infection. Its employment as a antigen in tests and point-of-care diagnostic platforms allows for specific interaction of immunoglobulins from infected individuals. The His label facilitates purification and assessment of the engineered A29L protein, thereby increasing the complete performance and specificity of the identification protocol. Further investigation into its incorporation into multiplex diagnostic arrays remains a promising domain of exploration.
Engineered Monkeypox A29L Protein (His Tag) Supply and Characteristics
The produced A29L molecule from Orthopoxvirus, featuring a His-tag for simple recovery, is now available for research use. This product is produced in E. coli and provided as a freeze-dried form, allowing for long-term storage. Usual characteristics include a size of approximately 140 kilodaltons, >90% cleanliness as evaluated by SDS-PAGE and a amount of 1 mg/mL in a solution of phosphate-buffered saline. Please the data sheet for detailed specs regarding shipping conditions and suggested keeping procedures.
Report this page